YVER ANTOINE 4
4 · Centessa Pharmaceuticals plc · Filed Apr 4, 2023
Insider Transaction Report
Form 4
YVER ANTOINE
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2023-03-31$3.90/sh−3,615$14,099→ 803,066 total - Sale
Ordinary Shares
2023-04-03$3.69/sh−6,700$24,730→ 796,366 total
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted shares. These sales were automatic and intended to qualify under Rule 10b5-1.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.